Upstream Bio Inc.

This study aims to check the long-term safety and effectiveness of an investigational drug called verekitug for adults with severe asthma. It is open only to people who have already finished a previous related trial called VALIANT. Researchers will monitor participants for side e…

This study is testing whether an investigational drug called verekitug can help control moderate-to-severe COPD. It will involve about 666 adults who are already on standard triple therapy for their COPD. The main goal is to see if the drug reduces the yearly rate of serious symp…